Lineage Cell Therapeutics, Inc. · AMEX:LCTX

Howe Jill Ann bought 20,000 Lineage Cell Therapeutics, Inc. shares (Form 4)

Traded Nov 16, 2026 · Filed Nov 16, 2026

On Nov 16, 2026, Howe Jill Ann (Chief Financial Officer) bought 20,000 Lineage Cell Therapeutics, Inc. shares at US$0.86 for US$17,100, leaving 45,500 shares. Filed Nov 16, 2026 (Form 4).

Bought
20,000 shares
Price
US$0.86
Value
US$17,100
Holding after
45,500 shares
Trading plan
No
Role
Chief Financial Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Nov 16, 2026Common SharesBuy20,000US$0.8645,500Direct

Source

Download original · View original at SEC

Related